Overcome the unique challenges of your trials with a proven head and neck cancer CRO
Head and neck cancer patients deserve new, innovative treatments to sustain and improve the quality of their lives. As a global head and neck cancer CRO with an integrated approach that combines medical, operational, and technological capabilities, we’re equipped to accelerate your treatment to market.
We support the full life cycle of clinical development in head-and-neck cancer, from early-phase dose-finding and proof-of-concept studies through pivotal registration trials and post-approval research. We provide comprehensive support, tailored to the unique requirements of your study — with capabilities spanning traditional interventional designs, adaptive platforms, basket/umbrella approaches, and real-world evidence generation.
Experience in the past 5 years in head and neck cancer
+
clinical projects
countries
+
sites
Navigating scientific complexities
Head and neck cancers pose many distinct challenges, including disease heterogeneity, cosmetic disfigurement, the need for complex multimodal treatments, specialized imaging requirements, and significant quality of life considerations. We meet those challenges head on with specialized medical expertise, experience with complex imaging, and a patient-centered approach that helps inform our quality-of-life measurements.
Advanced recruitment
This disease has a smaller patient population, making patient enrollment competitive. As an experienced head and neck cancer CRO, we use real-world data, AI-driven feasibility models, and our strong relationships with sites and advocacy groups to quickly find the right locations for your study.
Advanced recruitment
This disease has a smaller patient population, making patient enrollment competitive. As an experienced head and neck cancer CRO, we use real-world data, AI-driven feasibility models, and our strong relationships with sites and advocacy groups to quickly find the right locations for your study.
Global presence
Our teams are based in Europe, North America, and the APAC region, providing a global presence for high-quality medical oversight and monitoring. Our presence in APAC is particularly strong, with 8,800+ staff and 20+ offices across the region. Wherever you are, we’ll provide the integrated support you need.
Regulatory experience
Our team of 1,000+ global regulatory experts has experience with many authorities around the world, including FDA, EMA, MCC, MHRA, PMDA, BfArM, NMPA, and PEI. Our expertise as a leading oncology CRO allows us to navigate regulatory and market access hurdles around the world — so we can guide you along the best path to approval.